UQCRHL Inhibitors

The inhibitors listed for the protein UQCRHL target various components of the mitochondrial electron transport chain (ETC), a crucial process in cellular respiration responsible for generating adenosine triphosphate (ATP), the cell's primary energy currency. Rotenone and piericidin A are notable examples that bind to complex I of the ETC, interfering with the transfer of electrons from NADH to ubiquinone. By disrupting this step, these inhibitors impede the flow of electrons through the ETC, ultimately reducing ATP production.

Antimycin A and myxothiazol, on the other hand, act on complex III of the ETC. Antimycin A binds to complex III, preventing the transfer of electrons from ubiquinol to cytochrome c, while myxothiazol blocks the transfer of electrons from ubiquinol to cytochrome b. These inhibitors halt electron flow, disrupting the energy-generating process of oxidative phosphorylation.

Atpenin A5 and STX-140 are more selective inhibitors that specifically target UQCRHL within complex III. By inhibiting UQCRHL, they disrupt the flow of electrons between cytochrome b and cytochrome c1, further compromising ATP synthesis. Additionally, rotenone-oxime and duabine exert their inhibitory effects on complex I and complex III, respectively, contributing to the overall disruption of electron transport.

Methoxyacrylate, cytisine, cyrmenin A2, and benzoquinoneimine represent additional inhibitors that interfere with different stages of the electron transport process. These diverse inhibitors collectively serve as valuable tools for elucidating the role of UQCRHL in cellular metabolism and understanding the pathophysiology of diseases associated with mitochondrial dysfunction, such as neurodegenerative disorders and metabolic diseases. Their precise mechanisms of action highlight the intricate regulatory network of the mitochondrial electron transport chain and underscore the importance of UQCRHL as a target for various conditions associated with energy dysregulation.